This is a blend. BPC-157 and KPV are combined in a single 20 mg vial, 10 mg of each. Both are studied in inflammatory and tissue models from different mechanistic angles: BPC-157 is a synthetic 15 amino acid sequence characterised in preclinical models for angiogenesis and tissue remodelling, while KPV is the three amino acid tail of alpha-MSH and is characterised for NF-kB pathway endpoints. The combination has not been characterised as a single formulation.
The numbers that define BPC-157 / KPV and how it is being studied. For laboratory research use only.
2
Research Peptides
BPC-157 · KPV
20 mg
Total Per Vial
10 mg of each component
NF-kB
KPV Pathway
Inflammatory signalling
4
Research Areas
Inflammatory signalling
Tissue remodelling
Angiogenesis
How It Works
How BPC-157 / KPV works
The pathways BPC-157 / KPV acts on - and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Preclinical Remodelling
BPC-157
BPC-157 copies part of a protein found in gastric fluid. Preclinical models have measured new blood vessel growth, tendon cell migration and tissue remodelling after injury.
Angiogenesis endpoints
Tendon cell migration
Stable in acidic conditions
NF-kB Signalling
KPV
KPV is the C-terminal tripeptide of alpha-MSH. It carries the anti-inflammatory portion of that sequence without the pigmentation-associated portion, and NF-kB pathway endpoints are the characterised readouts.
alpha-MSH 11-13 fragment
NF-kB pathway endpoints
Small size, high stability
Two Signalling Angles
Combined
The vial pairs a long synthetic peptide with a three amino acid fragment. The two are characterised separately and no interaction data exists for the pair.
Remodelling and signalling arms
Matched handling
Interaction not characterised
Uses & Applications
What BPC-157 / KPV is researched for
The main areas BPC-157 / KPV is being studied for - and the study-reported figures behind them.
Cell Biology
Inflammatory Signalling
KPV is characterised for NF-kB pathway endpoints in cell models.
Cell Biology
Angiogenesis Models
BPC-157 has been measured for new blood vessel growth in preclinical models.
Cell Biology
Tissue Remodelling
Both peptides appear in tissue-remodelling literature from different angles.
Methods
Parallel Protocols
One vial holds both peptides under matched handling.
Study-reported magnitudes
Representative figures from published research. Bars fill as you scroll.
BPC-157 Preclinical ModelsCharacterised
KPV NF-kB EndpointsCharacterised
Inflammatory Signalling ReadoutsMeasured
Blend Interaction DataNone
Figures are representative of published research findings and shown for reference.
Molecular Structure
The BPC-157 / KPV molecule
An interactive 3D model rendered from the compound record - rotate and explore its structure.
Molecular model
Sequence length
blend
Physical form
Lyophilized powder blend
Documented purity
≥99% by HPLC
Compound Information
Full specification
Components
BPC-157 + KPV
Content
20 mg per vial (10 mg of each component)
BPC-157
Synthetic pentadecapeptide, CAS 137525-51-0
KPV
Lys-Pro-Val (α-MSH 11-13)
Form
Lyophilized powder blend
Purity
≥99% by HPLC
Appearance
White to off-white powder
Solubility
Water-soluble
Storage
-20°C, protected from light
Classification
Research use only
FAQ
Common questions about BPC-157 / KPV
They approach inflammatory and tissue research from different angles: BPC-157 through angiogenesis and remodelling endpoints in preclinical models, KPV through NF-kB pathway endpoints. One vial holds both under matched handling.
That is a separate three-peptide product that also contains TB-500 and is supplied at a different ratio. This vial holds only BPC-157 and KPV, 10 mg of each.
No. Each peptide is characterised separately and no interaction data exists for the pair.
The separate products let you control each peptide quantity independently and are offered in more than one size. This vial fixes the ratio at 10 mg and 10 mg.
Each lot is analysed by reverse-phase HPLC and released at ≥99%, with a Certificate of Analysis.
Store lyophilized at -20°C for long-term stability, protected from light and moisture, and avoid repeated freeze-thaw cycles.
Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.
